Diagnostic Study of Temporal Arteritis
Diagnostic Tools in Temporal Arteritis - Towards the Development of a Diagnostic Algorithm
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Despite a large and growing body of knowledge concerning the diagnosis of temporal arteritis, this potentially crippling disease still requires pathological diagnosis in practically every case. It seems likely that a correctly estimated clinical probability could help in evaluating imaging results in a way that might safely obviate temporal biopsy in a large segment of suspect cases. With this aim in view, we intend to identify useful clinical items and integrate them in an appropriate diagnostic pathway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2010
CompletedFirst Posted
Study publicly available on registry
May 26, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedMay 26, 2010
January 1, 2010
1.7 years
May 25, 2010
May 25, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Percent decrease in future biopsy use.
2 years
Secondary Outcomes (1)
No secondary outcome.
2 years
Eligibility Criteria
Inpatients suspected of temporal arteritis and referred to temporal artery biopsy
You may qualify if:
- Patients suspected of temporal arteritis and referred by their physicians to biopsy of a temporal artery.
You may not qualify if:
- Pregnancy; age \> 80 or \< 18; unable to answer study questions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Israel SA Heller, MD
Tel Aviv Medical Center, Tel Aviv, ISRAEL
Central Study Contacts
Ioni Tsechori, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 25, 2010
First Posted
May 26, 2010
Study Start
July 1, 2010
Primary Completion
March 1, 2012
Study Completion
July 1, 2012
Last Updated
May 26, 2010
Record last verified: 2010-01